EurekaMag
+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection


Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection



Radiation Oncology 13(1): 28



ISSN/ISBN: 1748-717X

PMID: 29463266

DOI: 10.1186/s13014-018-0974-5

Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal tumors occurring in various anatomic regions. Although diagnostic criteria and treatment management are not established, current treatment options consist of surgery and chemotherapy including mTOR inhibitors. Stereotactic body radiation therapy (SBRT) is a non-invasive ablative treatment which has shown excellent control rates for more common types of unresectable liver tumors and metastases. In this report we present a rare case of PEComa of the liver that was treated by stereotactic radiotherapy followed by resection. Staging and evaluation of treatment response was done by FDG-PET/CT. This case highlights the potential of SBRT as a neoadjuvant treatment even for rare liver malignancies. It is the first case of liver PEComa treated by SBRT and resection. A 52-year-old woman presented at an external hospital with abdominal pressure and pain in the right upper abdominal quadrant. A CT scan showed a 700 cm3 liver lesion in segment IV. In repeated biopsy in July 2015 histopathological workup showed a pleomorphic epitheloid tumor with small to medium sized cells expressing vimentin and melan-A while being negative for cytokeratin establishing the diagnosis of PEComa of the liver. To achieve high, ablative doses a stereotactic body radiotherapy (SBRT) technique was chosen consisting of 60Gy (biologically effective dose 105Gy) in 8 fractions of 7.5Gy. Radiotherapy planning was based on MRI resulting in a planning target volume (PTV) of 1944 cm3. Treatment toxicity was limited to a slight elevation of transaminases (grade 1 and 3). A complete resection was performed 21 weeks after radiotherapy confirmed by negative surgical margins. At last follow-up 21 months after therapy, MRI showed neither local nor distant tumor recurrence. The patient was in stable condition (ECOG 1) and without late radiation toxicity. This is the first documented case of liver PEComa treated by SBRT and resection. A favorable post-treatment course demonstrates that SBRT is a potential neoadjuvant treatment that is capable of reducing an inoperable rare liver tumor to a resectable lesion.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065652731

Download citation: RISBibTeXText

Related references

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma. Cancers 2(3): 1565-1575, 2010

Dosimetric Parameters Correlate With Node Negative Resection in Borderline and Initially Unresectable Pancreatic Adenocarcinoma Patients Treated With Stereotactic Body Radiation Therapy Followed by Surgical Resection. International Journal of Radiation Oncology*biology*physics 93(3): E183-E184, 2015

Stereotactic Body Radiation Therapy (SBRT) With or Without Daily Systemic Therapy for Re-Irradiation of Unresectable, Recurrent, Head and Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology Biology Physics 111(3s): E411-E412, 2021

Re-irradiation with SBRT (Stereotactic Body Radiation Therapy) for locoregional unresectable relapse of head and neck cancer: a case report. Anales del Sistema Sanitario de Navarra 42(3): 339-343, 2019

(P002) HER2 Status and Site of Metastases Predict Survival for Women Treated With Stereotactic Body Radiation Therapy/Stereotactic Radiosurgery (SBRT/SRS) for Oligometastases. Oncology 30 Suppl, 2016

Adaptive MR-Guided Stereotactic Body Radiation Therapy (AMR-SBRT) for Oligometastatic or Unresectable Primary Abdominal Malignancies: Results of a Prospective Phase I Trial. International Journal of Radiation Oncology*biology*physics 96(2): E205-E206, 2016

Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. International Journal of Radiation Oncology Biology Physics 67(3): 793-798, 2007

Safety and Efficacy of Second Stereotactic Body Radiation Therapy (SBRT) for Local Recurrence of Non-small Cell Lung Cancer (NSCLC) or Lung Metastasis Previously Treated With SBRT. International Journal of Radiation Oncology*biology*physics 84(3): S569-S570, 2012

GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in Combination with GC4711 in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer (PC). International Journal of Radiation Oncology Biology Physics 111(3s): E44-E45, 2021

Esophageal Dose Tolerance in Patients Treated With Stereotactic Body Radiation Therapy (SBRT). International Journal of Radiation Oncology*biology*physics 96(2): E474-E475, 2016

MA 09.06 Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy (SBRT): A Nationwide Survey of 1,378 Patients. Journal of Thoracic Oncology 12(11): S1836-S1837, 2017

Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT. International Journal of Radiation Oncology Biology Physics 90(2): 402-406, 2014

Acute Toxicity and Local Control in Pediatric Cancers Treated With Stereotactic Body Radiation Therapy (SBRT). International Journal of Radiation Oncology*biology*physics 93(3): E508-E509, 2015

Synchronous non small cell lung cancer nodules treated with stereotactic body radiation therapy (SBRT). Journal of Radiosurgery and Sbrt 3(1): 81-88, 2014

Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 142: 230-235, 2020